MLAB
Mesa Laboratories Inc
126.50$
-0.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 25.2% | 23.1% | 20.8% | 19.5% | 21.4% | 29.2% | 50.5% | 17.6% | 18.0% | 24.5% | 23.7% | 24.8% | |
| 1.7% | 3.5% | 3.4% | 3.3% | 6.5% | 19.4% | 43.9% | 7.0% | 5.0% | 6.3% | 6.3% | 6.3% | |
| 1.7% | 3.5% | 3.4% | 3.3% | 6.5% | 19.4% | 43.9% | 7.0% | 5.0% | 6.3% | 6.3% | 6.3% | |
| 10.4% | 9.5% | 8.3% | 8.7% | 8.0% | 5.0% | 4.0% | 5.8% | 6.4% | 8.7% | 9.7% | 10.3% | |
| 10.6% | 8.7% | 8.1% | 5.6% | 4.3% | 3.4% | 1.9% | 3.5% | 5.2% | 7.3% | 5.9% | 6.2% | |
| 8.2% | 10.3% | 15.1% | 14.4% | 14.2% | 5.3% | 3.7% | 4.0% | 4.3% | – | – | – | |
| 38.2% | 41.1% | 42.0% | 39.9% | 42.3% | 33.7% | 26.7% | 41.2% | 43.3% | 40.3% | 41.9% | 43.7% | |
| 28.3% | 25.4% | 22.0% | 26.1% | 21.2% | 28.5% | 18.6% | 35.4% | 2.8% | 25.5% | 22.4% | 19.5% | |
| 37.4% | 47.3% | 43.0% | 39.5% | 29.0% | 47.6% | 32.5% | 44.3% | 40.5% | 67.5% | 63.1% | 56.5% | |
| 12.5% | 14.9% | 9.6% | 10.5% | 15.1% | 6.2% | 5.4% | 6.8% | 6.6% | 9.9% | 37.8% | 14.5% | |
| 2.6% | 1.9% | 0.7% | 1.0% | 1.4% | 0.3% | 0.2% | 0.4% | 0.4% | 0.7% | 24.1% | 2.2% | |
| 2.1% | 1.8% | 1.3% | 1.5% | 1.8% | 0.8% | 0.7% | 1.1% | 0.9% | 1.4% | 1.3% | 1.2% | |
| 19.8% | 26.3% | 31.3% | 27.2% | 13.1% | 33.4% | 24.2% | 30.9% | 27.7% | 49.6% | 17.7% | 34.1% | |
| 62.6% | 52.7% | 57.0% | 60.5% | 71.0% | 52.4% | 67.5% | 55.7% | 59.5% | 32.5% | 36.9% | 43.5% | |
| 47.7% | 40.3% | 42.9% | 41.6% | 46.8% | 17.1% | 12.0% | 10.8% | 11.2% | -41.1% | -43.6% | -43.4% | |
| 3.1% | 2.3% | 2.2% | 2.3% | 2.6% | 1.0% | 0.9% | 0.8% | 0.8% | 1.2% | 1.3% | 1.3% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.